• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE GEVIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE GEVIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number DB-1200
Device Problem Unexpected Therapeutic Results (1631)
Patient Problems Shaking/Tremors (2515); Speech Disorder (4415); Unspecified Musculoskeletal problem (4535)
Event Date 02/16/2021
Event Type  Injury  
Event Description
It was reported that the patient experienced loss of stimulation and an increase of rigidity, dysarthria, and tremors.Reprogramming was performed, but the patient did not have the same coverage.The patients device settings were reviewed and when the system was turned off, the increased symptoms disappeared.The patients impedances are within normal range, but the patient increases their medication to compensate for the stimulation issues.Database analysis was performed and no device anomalies were found.An x-ray was also taken and the physician found no issues.The patient then underwent a revision procedure to explant and replace the implantable pulse generator (ipg).The patient is stable and doing well postoperatively.
 
Manufacturer Narrative
With all available information, boston scientific concludes through laboratory analysis that the event loss of stimulation and the increase of rigidity, dysarthria, and tremors were not able to be confirmed as the ipg passed all tests performed.Additionally, the event of the increase of rigidity, dysarthria, and tremors are known inherent risks with the use of deep brain stimulation as documented in the instructions for use (ifu).The returned db-1200 ipg was analyzed, passed all tests performed, and exhibited normal device characteristics.A product labeling review identified that the device was used per the instructions for use (ifu) / product label.The ifu states that the following is a list of known risks with the use of deep brain stimulation: embolism, including air embolism and pulmonary embolism, hemorrhagic or ischemic stroke, immediate or delayed, which could result in temporary or permanent neurologic deficits such as muscle weakness, paralysis or aphasia peripheral nerves, brain (including pneumocephalus), or pleura (including pneumothorax), loss of adequate stimulation, mentation impairment such as attention or cognitive deficits, memory disturbances, or confusion, motor problems such as paresis, weakness, incoordination, restlessness, muscle spasms, postural and gait disorders, tremor, dystonia, or dyskinesias, and falls or injuries resulting from these problem, musculoskeletal stiffness, neuroleptic malignant syndrome or acute akinesia can occur very rarely, overstimulation or undesirable sensations, such as paresthesia, transient or persistent, pain, headache or discomfort, transient or persistent, including symptoms due to neurostimulation.
 
Event Description
It was reported that the patient experienced an increase of rigidity, dysarthria, and loss of stimulation.Reprogramming was performed, but the patient did not have the same coverage.The patient's device settings were reviewed and when the system was turned off, the increased symptoms disappeared.The patient's device exhibits good impedances, but the patient increases their medication to compensate for the inadequate stimulation.An x-ray was taken and the physician found no issues.The patient then underwent a revision procedure to explant and replace the implantable pulse generator (ipg).The patient is stable and doing well postoperatively.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE GEVIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
25155 rye canyon loop
valencia CA 91355
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key13582803
MDR Text Key285982943
Report Number3006630150-2022-00643
Device Sequence Number1
Product Code MHY
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/30/2019
Device Model NumberDB-1200
Device Catalogue NumberDB-1200
Device Lot Number21449255
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/18/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/30/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-